Moxalactam Therapy of Bacterial Meningitis in Adults

The therapeutic efficacy and attainable cerebrospinal fluid (CSF) concentrations of moxalactam, administered by intravenous drip in a dose of 2 g every 4 to 8 h, were evaluated in seven adult patients with bacterial meningitis. Streptococcus pneumoniae, Staphylococcus aureus, Pseudomonas aeruginosa,...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Uwaydah, Marwan, Tannir, Nizar, Kantarjian, Hagop, Osseiran, Maher, Bal'a, Farid
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1983
Assuntos:	Clinical Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC186039/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6220673/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.23.2.289
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!